A Novel Integrated VMAT/IMRT Technique for the Treatment of Non-Small Cell Lung Cancer:Novel Therapies/Experimental Therapies (English)
- New search for: Zhao, N.
- New search for: Yang, R.
- New search for: Wang, J.
- New search for: Zhao, N.
- New search for: Yang, R.
- New search for: Wang, J.
In:
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
;
90
, 5
;
S54-S55
;
2014
-
ISSN:
- Article (Journal) / Print
-
Title:A Novel Integrated VMAT/IMRT Technique for the Treatment of Non-Small Cell Lung Cancer:Novel Therapies/Experimental Therapies
-
Contributors:
-
Published in:INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS ; 90, 5 ; S54-S55
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2014-01-01
-
Size:S54-S55
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.9940 / 616
- Further information on Dewey Decimal Classification
-
Classification:
-
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 90, Issue 5
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 975
-
The State of Radiation Therapy in the State of IsraelCorn, B. W. / Symon, Z. / Gamzu, R. et al. | 2014
- 979
-
Radiation Dose in Non-Small Cell Lung Cancer: Too Much of a Good Thing?Dilling, T. J. et al. | 2014
- 983
-
Revisiting the Sustainable Growth Rate “Hole”: Sources of Healthcare Cost Stabilization in 2010-2012Maroongroge, S. / Dosoretz, A. P. / Kim, S. P. / Gross, C. P. / Yu, J. B. et al. | 2014
- 986
-
Is Financial Literacy Necessary for Radiation Oncology Residents?Witek, M. / Siglin, J. / Malatesta, T. / Snook, A. / Gressen, E. / Rudoler, S. / Bar-Ad, V. / Fisher, S. et al. | 2014
- 988
-
A Report on Quality and Safety Education for Radiation Oncology ResidentsFogh, S. / Pawlicki, T. et al. | 2014
- 990
-
Whole-Breast Radiation Therapy: The Long and Short of ItMowery, Y. M. / Blitzblau, R. C. et al. | 2014
- 993
-
Adoption of Hypofractionated Whole-Breast Irradiation for Early-Stage Breast Cancer: A National Cancer Data Base AnalysisWang, E. H. / Mougalian, S. S. / Soulos, P. R. / Rutter, C. E. / Evans, S. B. / Haffty, B. G. / Gross, C. P. / Yu, J. B. et al. | 2014
- 1001
-
Adoption of Hypofractionated Radiation Therapy for Breast Cancer After Publication of Randomized TrialsJagsi, R. / Falchook, A. D. / Hendrix, L. H. / Curry, H. / Chen, R. C. et al. | 2014
- 1010
-
Choosing Wisely? Patterns and Correlates of the Use of Hypofractionated Whole-Breast Radiation Therapy in the State of MichiganJagsi, R. / Griffith, K. A. / Heimburger, D. / Walker, E. M. / Grills, I. S. / Boike, T. / Feng, M. / Moran, J. M. / Hayman, J. / Pierce, L. J. et al. | 2014
- 1017
-
Long-term Outcomes of Hypofractionation Versus Conventional Radiation Therapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ of the BreastLalani, N. / Paszat, L. / Sutradhar, R. / Thiruchelvam, D. / Nofech-Mozes, S. / Hanna, W. / Slodkowska, E. / Done, S. J. / Miller, N. / Youngson, B. et al. | 2014
- 1025
-
Long-Term Results From the Contura Multilumen Balloon Breast Brachytherapy Catheter Phase 4 Registry TrialCuttino, L. W. / Arthur, D. W. / Vicini, F. / Todor, D. / Julian, T. / Mukhopadhyay, N. et al. | 2014
- 1030
-
[18F]-Fluoromisonidazole Positron Emission Tomography/Computed Tomography Visualization of Tumor Hypoxia in Patients With Chordoma of the Mobile and Sacrococcygeal SpineCheney, M. D. / Chen, Y. L. / Lim, R. / Winrich, B. K. / Grosu, A. L. / Trofimov, A. V. / Depauw, N. / Shih, H. A. / Schwab, J. H. / Hornicek, F. J. et al. | 2014
- 1037
-
The Modern Role of Radiation Therapy in Treating Advanced-Stage Retinoblastoma: Long-Term Outcomes and Racial DifferencesOrman, A. / Koru-Sengul, T. / Miao, F. / Markoe, A. / Panoff, J. E. et al. | 2014
- 1044
-
Outcomes of Proton Therapy for the Treatment of Uveal MetastasesKamran, S. C. / Collier, J. M. / Lane, A. M. / Kim, I. / Niemierko, A. / Chen, Y. L. / MacDonald, S. M. / Munzenrider, J. E. / Gragoudas, E. / Shih, H. A. et al. | 2014
- 1051
-
A Prospective Phase 2 Multicenter Study for the Efficacy of Radiation Therapy Following Incomplete Transarterial Chemoembolization in Unresectable Hepatocellular CarcinomaChoi, C. / Koom, W. S. / Kim, T. H. / Yoon, S. M. / Kim, J. H. / Lee, H. S. / Nam, T. K. / Seong, J. et al. | 2014
- 1061
-
Stereotactic Ablative Body Radiation Therapy for Primary Kidney Cancer: A 3-Dimensional Conformal Technique Associated With Low Rates of Early ToxicityPham, D. / Thompson, A. / Kron, T. / Foroudi, F. / Kolsky, M. S. / Devereux, T. / Lim, A. / Siva, S. et al. | 2014
- 1069
-
A Dose–Response Analysis of Biochemical Control Outcomes After 125I Monotherapy for Patients With Favorable-Risk Prostate CancerShiraishi, Y. / Yorozu, A. / Ohashi, T. / Toya, K. / Saito, S. / Nishiyama, T. / Yagi, Y. / Shigematsu, N. et al. | 2014
- 1076
-
Low Interrater Reliability in Grading of Rectal Bleeding Using National Cancer Institute Common Toxicity Criteria and Radiation Therapy Oncology Group Toxicity Scales: A Survey of Radiation OncologistsHuynh-Le, M. P. / Zhang, Z. / Tran, P. T. / DeWeese, T. L. / Song, D. Y. et al. | 2014
- 1083
-
National Cancer Data Base Analysis of Radiation Therapy Consolidation Modality for Cervical Cancer: The Impact of New Technological AdvancementsGill, B. S. / Lin, J. F. / Krivak, T. C. / Sukumvanich, P. / Laskey, R. A. / Ross, M. S. / Lesnock, J. L. / Beriwal, S. et al. | 2014
- 1091
-
Extended Field Intensity Modulated Radiation Therapy With Concomitant Boost for Lymph Node–Positive Cervical Cancer: Analysis of Regional Control and Recurrence Patterns in the Positron Emission Tomography/Computed Tomography EraVargo, J. A. / Kim, H. / Choi, S. / Sukumvanich, P. / Olawaiye, A. B. / Kelley, J. L. / Edwards, R. P. / Comerci, J. T. / Beriwal, S. et al. | 2014
- 1099
-
[18F]FDG-PET Standard Uptake Value as a Metabolic Predictor of Bone Marrow Response to Radiation: Impact on Acute and Late Hematological Toxicity in Cervical Cancer Patients Treated With Chemoradiation TherapyElicin, O. / Callaway, S. / Prior, J. O. / Bourhis, J. / Ozsahin, M. / Herrera, F. G. et al. | 2014
- 1108
-
Mucosal Melanoma of the Head and Neck: A Systematic Review of the LiteratureLazarev, S. / Gupta, V. / Hu, K. / Harrison, L. B. / Bakst, R. et al. | 2014
- 1119
-
Comprehensive Craniospinal Radiation for Controlling Central Nervous System LeukemiaWalker, G. V. / Shihadeh, F. / Kantarjian, H. / Allen, P. / Rondon, G. / Kebriaei, P. / O'Brien, S. / Kedir, A. / Said, M. / Grant, J. D. et al. | 2014
- 1126
-
A Decade of Comparative Dose Planning Studies for Early-Stage Hodgkin Lymphoma: What Can We Learn?Maraldo, M. V. / Specht, L. et al. | 2014
- 1136
-
Predicting Outcome in Patients with Rhabdomyosarcoma: Role of [18F]Fluorodeoxyglucose Positron Emission TomographyCasey, D. L. / Wexler, L. H. / Fox, J. J. / Dharmarajan, K. V. / Schoder, H. / Price, A. N. / Wolden, S. L. et al. | 2014
- 1143
-
Outcomes and Acute Toxicities of Proton Therapy for Pediatric Atypical Teratoid/Rhabdoid Tumor of the Central Nervous SystemMcGovern, S. L. / Okcu, M. F. / Munsell, M. F. / Kumbalasseriyil, N. / Grosshans, D. R. / McAleer, M. F. / Chintagumpala, M. / Khatua, S. / Mahajan, A. et al. | 2014
- 1153
-
Neoadjuvant Sandwich Treatment With Oxaliplatin and Capecitabine Administered Prior to, Concurrently With, and Following Radiation Therapy in Locally Advanced Rectal Cancer: A Prospective Phase 2 TrialGao, Y. H. / Lin, J. Z. / An, X. / Luo, J. L. / Cai, M. Y. / Cai, P. Q. / Kong, L. H. / Liu, G. C. / Tang, J. H. / Chen, G. et al. | 2014
- 1161
-
Pretreatment Evaluation of Microcirculation by Dynamic Contrast-Enhanced Magnetic Resonance Imaging Predicts Survival in Primary Rectal Cancer PatientsDeVries, A. F. / Piringer, G. / Kremser, C. / Judmaier, W. / Saely, C. H. / Lukas, P. / Öfner, D. et al. | 2014
- 1168
-
Local Control and Toxicity in a Large Cohort of Central Lung Tumors Treated With Stereotactic Body Radiation TherapyModh, A. / Rimner, A. / Williams, E. / Foster, A. / Shah, M. / Shi, W. / Zhang, Z. / Gelblum, D. Y. / Rosenzweig, K. E. / Yorke, E. D. et al. | 2014
- 1177
-
Preclinical Evaluation of Bioabsorbable Polyglycolic Acid Spacer for Particle TherapyAkasaka, H. / Sasaki, R. / Miyawaki, D. / Mukumoto, N. / Sulaiman, N. S. / Nagata, M. / Yamada, S. / Murakami, M. / Demizu, Y. / Fukumoto, T. et al. | 2014
- 1186
-
Impact of Intrafraction and Residual Interfraction Effect on Prostate Proton Pencil Beam ScanningTang, S. / Deville, C. / Tochner, Z. / Wang, K. K. / McDonough, J. / Vapiwala, N. / Both, S. et al. | 2014
- 1195
-
Institutional Patient-specific IMRT QA Does Not Predict Unacceptable Plan DeliveryKry, S. F. / Molineu, A. / Kerns, J. R. / Faught, A. M. / Huang, J. Y. / Pulliam, K. B. / Tonigan, J. / Alvarez, P. / Stingo, F. / Followill, D. S. et al. | 2014
- 1202
-
A Real-Time Safety and Quality Reporting System: Assessment of Clinical Data and Staff ParticipationRahn, D. A. / Kim, G. Y. / Mundt, A. J. / Pawlicki, T. et al. | 2014
- 1208
-
Adaptive Replanning to Account for Lumpectomy Cavity Change in Sequential Boost After Whole-Breast IrradiationChen, X. / Qiao, Q. / DeVries, A. / Li, W. / Currey, A. / Kelly, T. / Bergom, C. / Wilson, J. F. / Li, X. A. et al. | 2014
- 1216
-
Retrospective Reconstructions of Active Bone Marrow Dose-Volume HistogramsVeres, C. / Allodji, R. S. / Llanas, D. / Vu Bezin, J. r. / Chavaudra, J. / Mège, J. P. / Lefkopoulos, D. / Quiniou, E. / Deutsh, E. / de Vathaire, F. et al. | 2014
- 1225
-
Automated Segmentation of the Parotid Gland Based on Atlas Registration and Machine Learning: A Longitudinal MRI Study in Head-and-Neck Radiation TherapyYang, X. / Wu, N. / Cheng, G. / Zhou, Z. / Yu, D. S. / Beitler, J. J. / Curran, W. J. / Liu, T. et al. | 2014
- 1234
-
A Simple and Efficient Methodology To Improve Geometric Accuracy in Gamma Knife Radiation Surgery: Implementation in Multiple Brain MetastasesKaraiskos, P. / Moutsatsos, A. / Pappas, E. / Georgiou, E. / Roussakis, A. / Torrens, M. / Seimenis, I. et al. | 2014
- 1242
-
Global Harmonization of Quality Assurance Naming Conventions in Radiation Therapy Clinical TrialsMelidis, C. / Bosch, W. R. / Izewska, J. / Fidarova, E. / Zubizarreta, E. / Ulin, K. / Ishikura, S. / Followill, D. / Galvin, J. / Haworth, A. et al. | 2014
- 1250
-
Modelling the Impact of Fractionation on Late Urinary Toxicity After Postprostatectomy Radiation TherapyFiorino, C. / Cozzarini, C. / Rancati, T. / Briganti, A. / Cattaneo, G. M. / Mangili, P. / Di Muzio, N. G. / Calandrino, R. et al. | 2014
- 1258
-
In Regard to Olson et al and Ellsworth et alRajagopalan, M. S. / Beriwal, S. / Heron, D. E. et al. | 2014
- 1258
-
In Regard to Fokas et alWeiss, S. E. et al. | 2014
- 1259
-
In Reply to Weiss et alFokas, E. / Henzel, M. / Engenhart-Cabillic, R. et al. | 2014
- 1260
-
In Regard to ZietmanRaju, M. R. et al. | 2014
- 1261
-
In Reply to RajuZietman, A. L. et al. | 2014
- 1262
-
Erratum to Blanck O, Bode F, Gebhard M, et al. Dose-Escalation Study for Cardiac Radiosurgery in a Porcine Model. Int J Radiat Oncol Biol Phys 2014;89:590–598.| 2014
- 1262
-
Erratum to: Moran MS, Houssami N, Schnitt SJ, Morrow M. In reply to Dixon and Thomas. Int J Radiat Oncol Biol Phys 2014;89:1139-1141.| 2014
- 1262
-
Erratum to: Duchesne GM, Turner SL, Cronje S. Around the Globe-Radiation Oncology in Australia. Int J Radiat Oncol Biol Phys 2014;90:1-6.| 2014
- 1262
-
Erratum to: Chan RJ, Mann J, Tripcony L, et al. Natural Oil-Based Emulsion Containing Allantoin Versus Aqueous Cream for Managing Radiation-Induced Skin Reactions in Patients With Cancer: A Phase 3, Double-Blind, Randomized, Controlled Trial. Int J Radiat Oncol Biol Phys 2014 Aug 20 [Epub ahead of print]. http://dx.doi.org/10.1016/j.ijrobp.2014.06.034.| 2014
- 1263
-
Initial Results of a Phase 3 Randomized Study of High Dose 3DCRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer (RTOG 0126)Michalski, J. M. / Moughan, J. / Purdy, J. A. / Bosch, W. R. / Bahary, J. / Lau, H. / Duclos, M. / Parliament, M. / Morton, G. / Hamstra, D. A. et al. | 2014
- 1263
-
ICORG 05-03: Prospective Randomized Non-Inferiority Phase 3 Trial Comparing Two Radiation Schedules in Malignant Spinal Cord Compression not Proceeding with Surgical DecompressionThirion, P. / O'Sullivan, L. / Clayton-Lea, A. / Small, C. / McArdle, O. / Kelly, P. / Parker, I. / O'Sullivan, J. / Hacking, D. / Collins, C. et al. | 2014
- 1264
-
Hypofractionated Whole Breast Irradiation Results in Less Acute Toxicity and Improved Quality of Life at Six Months Compared to Conventionally Fractionated Whole Breast Irradiation: Results of a Randomized TrialShaitelman, S. F. / Buchholz, T. A. / Hunt, K. K. / Hortobagyi, G. N. / Schlembach, P. / Arzu, I. / Bloom, E. / Chronowski, G. / Dvorak, T. / Grade, E. et al. | 2014
- 1264
-
2014 Annual Meeting Abstract Errata| 2014
- 1266
-
Phase II Study of Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer:Metastatic Non-small Cell Lung CancerRamalingam, S. S. / Mazières, J. / Planchard, D. / Stinchcombe, T. E. / Dy, G. K. / Antonia, S. J. / Horn, L. / Lena, H. / Minenza, E. / Mennecier, B. et al. | 2014
- 1266
-
Efficacy and Safety of Eribulin Compared with Treatment of Physician’s Choice (TPC) in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC): Results from a Phase 3 Study:Locally Advanced Non-small Cell Lung CancerSpigel, D. R. / Barlesi, F. / Felip, E. / Kim, J. / Olivo, M. / Nokihara, H. / Yang, J. C. / Satouchi, M. / Katakami, N. / Iannotti, N. et al. | 2014
- 1268
-
Meetings| 2014
- A5
-
Steering/Program Committees| 2014
- A13
-
Issue Highlights| 2014
- S1
-
Safety and Clinical Activity of MK-3475 as Initial Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC):Novel Therapies/Experimental TherapiesBalmanoukian, A. S. / Rizvi, N. A. / Garon, E. B. / Patnaik, A. / Gandhi, L. / Leighl, N. B. / Goldman, J. W. / Eder, J. P. / Johnson, E. A. / Blumenschein, G. R. et al. | 2014
- S2
-
Adjuvant Erlotinib (E) Versus Placebo (P) for Completely Resected Stage IB-IIIA EGFR-Positive (IHC/FISH) Non-Small Cell Lung Cancer (NSCLC): RADIANT Results:Locally Advanced Non-Small Cell Lung CancerAltorki, N. K. / O'brien, M. E. / Eberhardt, W. E. / Richardson, F. C. / Wang, J. / Foley, M. A. / Horan, J. D. / Shepherd, F. A. / Kelly, K. et al. | 2014
- S3
-
Metabolic Tumor Volume Predicts Overall Survival in Patients With Stage III Non-Small Cell Lung Cancer Treated on ACRIN 6668/RTOG 0235:Locally Advanced Non-Small Cell Lung CancerBazan, J. G. / Duan, F. / Snyder, B. S. / Horng, D. / Graves, E. E. / Siegel, B. A. / Machtay, M. / Loo, B. W. et al. | 2014
- S4
-
A Randomized, Double-Blind, Phase 2 Trial of Veliparib (ABT-888) With Carboplatin and Paclitaxel in Previously Untreated Metastatic or Advanced Non-Small Cell Lung Cancer:Metastatic Non-Small Cell Lung CancerRamalingam, S. / Blais, N. / Mazieres, J. / Reck, M. / Jones, C. M. / Juhasz, E. / Urban, L. / Orlov, S. / Barlesi, F. / Kio, E. et al. | 2014
- S5
-
Overall Survival (OS) With Afatinib Versus Chemotherapy in Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC) Harboring Common (Del19/L858R) Epidermal Growth Factor Receptor Mutations (EGFR Mut): Results of LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6):Metastatic Non-Small Cell Lung CancerSequist, L. / Wu, Y. / Schuler, M. / O'Byrne, K. / Sebastian, M. / Popat, S. / Boyer, M. / Mok, T. / Yamamoto, N. / Hirsh, V. et al. | 2014
- S6
-
Variation in Mechanisms of Acquired Resistance Among EGFR-Mutant NSCLC Patients With More Than 1 Postresistant Biopsy:Metastatic Non-Small Cell Lung CancerPiotrowska, Z. / Niederst, M. J. / Mino-Kenudson, M. / Morales-Oyarvide, V. / Fulton, L. / Lockerman, E. / Howe, E. / Gainor, J. F. / Fidias, P. / Heist, R. S. et al. | 2014
- S7
-
Low-Dose CT Lung Cancer Screening Practices and Attitudes Among Primary Care Providers at an Academic Medical Center:Prevention/ScreeningLewis, J. / Petty, W. J. / Tooze, J. A. / Miller, D. P. / Chiles, C. / Miller, A. A. / Weaver, K. E. et al. | 2014
- S9
-
Costs of the Diagnostic Workup for Lung Cancer: A Medicare Claims Analysis:Diagnosis/StagingLokhandwala, T. / Dann, R. / Johnson, M. / D'Souza, A. O. et al. | 2014
- S10
-
Four-Dimensional Diffusion-Weighted Magnetic Resonance Imaging (4D-DWI): Development and Evaluation:Diagnosis/StagingLiu, Y. / Yin, F. / Czito, B. / Mustafa, B. R. / Cai, J. et al. | 2014
- S12
-
Adjuvant Chemotherapy for Older Patients With Early-Stage Non-Small Cell Lung Cancer:Early-Stage Non-Small Cell Lung CancerGanti, A. / Williams, C. / Gajra, A. / Kelley, M. J. et al. | 2014
- S13
-
A Decade of “50 in 5”: Maturing SBRT Outcomes for Medically Inoperable Early-Stage Lung Cancer at a Single Institution Over 10 Years:Early-Stage Non-Small Cell Lung CancerVidetic, G. M. / Reddy, C. / Woody, N. / Djemil, T. / Stephans, K. et al. | 2014
- S14
-
Recurrence Patterns and Second Primary Lung Cancers After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: Implications for Surveillance:Early-Stage Non-Small Cell Lung CancerRimner, A. / Adeseye, V. / Foster, A. / Woo, K. M. / Shaikh, F. / Din, S. / Zhang, Z. / Yorke, E. D. / Gewanter, R. / Rosenzweig, K. E. et al. | 2014
- S15
-
Phase 2 Trial of Preoperative Pemetrexed (P)/Carboplatin (C) in Patients (Pts) With Select Stage IB, II, and III Nonsquamous Non-Small Cell Lung Cancer (NS-NSCLC):Early-Stage Non-Small Cell Lung CancerSpigel, D. R. / Waterhouse, D. M. / Shih, K. C. / Boccia, R. V. / Priego, V. M. / McCleod, M. J. / Townsend, D. C. / Kudrik, F. K. / Mitchell, R. B. / Burris, H. A. et al. | 2014
- S18
-
Comparing Risk of Radiation Pneumonitis After Intensity Modulated Radiation Therapy Versus Proton Therapy:Locally Advanced Non-Small Cell Lung CancerLiao, Z. / Mohan, R. / Xu, T. / Cox, J. D. / Tucker, S. L. et al. | 2014
- S19
-
The 5-Year Outcome for Patients Diagnosed With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Concurrent Chemotherapy and Proton Beam Therapy:Locally Advanced Non-Small Cell Lung CancerNguyen, Q. / Komaki, R. / Liao, Z. / Ly, N. / Levy, L. / Gomez, D. / Chang, J. / Cox, J. D. et al. | 2014
- S20
-
Safety and Efficacy of Stereotactic Body Radiation Therapy (SBRT) Reirradiation for New or Recurrent Pulmonary Malignancies Following Previous In-Field Conventionally Fractionated Thoracic Radiation Therapy (CFRT):Locally Advanced Non-Small Cell Lung CancerHeskel, M. / Xanthopoulos, E. P. / Berman, A. T. / Levin, W. / Vachani, A. / Haas, A. / Sterman, D. H. / Lanfranco, A. / Moon, E. / Corradetti, M. N. et al. | 2014
- S21
-
Phase 1 Study of CT-Guided Interstitial 3-Dimensional (3D) Brachytherapy for Peripheral Non-Small Cell Lung Cancer:Locally Advanced Non-Small Cell Lung CancerJingBo, W. / Xiang, L. / JianWen, Z. / Sheng, L. / HuiQun, L. / QingLian, W. / LiJia, H. / ChangLing, S. / PeiRong, R. et al. | 2014
- S22
-
Safety Data Analyses for First-Line Pemetrexed Plus Carboplatin (Pem+Cb) in Nonsquamous Non-Small Cell Lung Cancer (ns-NSCLC):Locally Advanced Non-Small Cell Lung CancerOkamoto, I. / Schuette, W. / Stinchcombe, T. / Rodrigues Pereira, J. / Liu, J. / San Antonio, B. / John, W. / Chen, J. / Zinner, R. et al. | 2014
- S23
-
Variability of Interfraction Target Motion During Conventional and Hypofractionated Lung Radiation Therapy:Locally Advanced Non-Small Cell Lung CancerJawad, M. S. / Vance, S. M. / Grills, I. S. / Ye, H. / Prausa, S. K. / Wloch, J. / Yan, D. et al. | 2014
- S24
-
Correlation of PET/CT Response to the Mediastinal Down-Staging in Operable NSCLC: Impact of RT Dose:Locally Advanced Non-Small Cell Lung CancerTuraka, A. / Hasan, S. / Li, T. / Mehra, R. / Scott, W. J. / Yu, J. Q. et al. | 2014
- S25
-
Prognostic Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Radiation Therapy:Locally Advanced Non-Small Cell Lung CancerKumar, S. / Movsas, B. / Brown, S. L. / Simoff, M. / Stone, C. H. / Jenrow, K. A. / Lapanowski, K. / Ajlouni, M. / Chetty, I. J. / Movsas, A. et al. | 2014
- S26
-
The Important Prognostic Value of Pretreatment Stage in Patients Achieving Pathologic Complete Response After Neoadjuvant Therapy of Esophageal Cancer:Mesothelioma, Thymic Malignancies, and Other Thoracic MalignanciesYang, J. / Xiao, Z. / Tan, L. / Zhou, Z. / Feng, Q. / Wang, L. / Zhang, H. / Chen, D. / Liang, J. / Hui, Z. et al. | 2014
- S27
-
Radiation-Induced Malignant Mesothelioma: Frequency and Prognosis:Mesothelioma, Thymic Malignancies, and Other Thoracic MalignanciesBarsky, A. R. / Friedberg, J. S. / Culligan, M. / Sterman, D. H. / Alley, E. / Litzky, L. A. / Glatstein, E. / Hahn, S. M. / Cengel, K. A. / Simone, C. B. et al. | 2014
- S30
-
SBRT for Lung Metastases: Should We, Should We Not?:Mesothelioma, Thymic Malignancies, and Other Thoracic MalignanciesDuma, M. / Kroll, L. / Oechsner, M. / Andratschke, N. / Molls, M. et al. | 2014
- S31
-
Safety and Efficacy of Necitumumab (N) During Single-Agent Treatment to Progression Following Gemcitabine-Cisplatin (GC) Chemotherapy Plus Necitumumab (IMC-11F8/LY3012211) in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (sq-NSCLC) (SQUIRE):Metastatic Non-Small Cell Lung CancerSocinski, M. A. / Thatcher, N. / Luft, A. V. / Szczesna, A. / Ciuleanu, T. / Szafrański, W. / Ramlau, R. / Bálint, B. / Kazarnowicz, A. / Molinier, O. et al. | 2014
- S32
-
Safety and Efficacy of First-Line Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) and Ipilimumab in Non-Small Cell Lung Cancer (NSCLC):Metastatic Non-Small Cell Lung CancerAntonia, S. J. / Gettinger, S. / Goldman, J. / Chow, L. Q. / Juergens, R. / Borghaei, H. / Brahmer, J. R. / Shen, Y. / Harbison, C. / Chen, A. C. et al. | 2014
- S33
-
Efficacy and Safety of Ceritinib in Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Rearranged (ALK+) Non-Small Cell Lung Cancer (NSCLC): An Update of ASCEND-1:Metastatic Non-Small Cell Lung CancerKim, D. / Mehra, R. / Tan, D. S. / Felip, E. / Chow, L. Q. / Camidge, D. R. / Vansteenkiste, J. / Sharma, S. / De Pas, T. / Riely, G. J. et al. | 2014
- S34
-
Safety and Response With Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) Plus Erlotinib in Patients (Pts) With Epidermal Growth Factor Receptor Mutant (EGFR MT) Advanced Non-Small Cell Lung Cancer (NSCLC):Metastatic Non-Small Cell Lung CancerGettinger, S. / Chow, L. Q. / Borghaei, H. / Shen, Y. / Harbison, C. / Chen, A. C. / Rizvi, N. A. et al. | 2014
- S35
-
Enrichment of Met Amplification and Kras Mutations in Non-Small Cell Lung Carcinoma (NSCLC) Brain Metastases:Metastatic Non-Small Cell Lung CancerVillaruz, L. C. / Socinski, M. A. / Derrick, V. / Bartoluzzi, S. A. / Kurland, B. / Nikiforova, M. / Burns, T. F. / Siegfried, J. / Hamilton, R. / Dacic, S. et al. | 2014
- S36
-
The Impact of RTOG 0614 and RTOG 0933 in Routine Clinical Practice: The U.S. Survey of Utilization of Memantine and IMRT Planning for Hippocampus Sparing in Patients Receiving Whole-Brain Radiation Therapy for Brain Metastases:Metastatic Non-Small Cell Lung CancerSlade, A. / Stanic, S. et al. | 2014
- S37
-
Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC): Results From a Phase 2, Placebo-Controlled Study (GO27821):Metastatic Non-Small Cell Lung CancerWakelee, H. A. / Zvirbule, Z. / De Braud, F. / Kingsley, C. D. / Mekhail, T. / Schütte, W. / Lena, H. / Lawler, W. / Braiteh, F. / Cosgriff, T. et al. | 2014
- S38
-
Phase 1 Trial of Icotinib Combined With Whole-Brain Radiation Therapy for EGFR-Mutated Non-Small Cell Lung Cancer Patients With Brain Metastases: Updated Results:Metastatic Non-Small Cell Lung CancerZhou, L. / He, J. / Xiong, W. / Yu, Q. / Xiang, J. / Liang, M. / Xue, J. / Liu, Y. / Ding, Z. / Gong, Y. et al. | 2014
- S39
-
Continued Afatinib (A) With the Addition of Cetuximab (C) After Progression on Afatinib in Patients With Acquired Resistance (AR) to Gefitinib (G) or Erlotinib (E):Metastatic Non-Small Cell Lung CancerHorn, L. / Gettinger, S. / Camidge, R. / Smit, E. / Janjigian, Y. / Pao, W. / Schnell, D. / Wang, B. / Chand, V. / Groen, H. et al. | 2014
- S40
-
Risk of Brain Metastasis in EGFR-Mutant NSCLC Treated With Erlotinib: A Role for Prophylactic Cranial Irradiation?:Metastatic Non-Small Cell Lung CancerPatel, S. / Rimner, A. / Foster, A. / Zhang, Z. / Woo, K. M. / Yu, H. A. / Riely, G. J. / Wu, A. J. et al. | 2014
- S41
-
Stereotactic Body Radiation Therapy for Oligometastatic Pulmonary Lesions:Metastatic Non-Small Cell Lung CancerHeskel, M. / Xanthopoulos, E. P. / Cohen, R. B. / Aggarwal, C. / Evans, T. / Alley, E. / Algazy, K. / Berman, A. T. / Levin, W. / Cengel, K. A. et al. | 2014
- S42
-
The Use of Patient-Derived Xenograft (PDX) Models to Predict Patient Response in Non-Small Cell Lung Cancer (NSCLC):Metastatic Non-Small Cell Lung CancerIsler, J. / Katz, A. / Sorogin, A. / Scoppetuolo, M. / Nechushtan, H. / Pass, H. / Davies, A. / Paz, K. et al. | 2014
- S43
-
Acquired Resistance to Afatinib in EGFR-Mutant Lung Cancer:Metastatic Non-small Cell Lung CancerSequist, L. V. / Gerber, D. E. / Fidias, P. / Shaw, A. T. / Temel, J. S. / Heist, R. S. / Gainor, J. F. / Fulton, L. / Kennedy, E. A. / Muzikansky, A. et al. | 2014
- S44
-
Economic Burden and Treatments of Progression to Metastatic Disease in ALK+ NSCLC Patients:Metastatic Non-Small Cell Lung CancerGuérin, A. / Sasane, M. / Zhang, J. / Culver, K. / Macalalad, A. / Nitulescu, R. / Wu, E. / Dea, K. et al. | 2014
- S45
-
Pattern of Failure in Metastatic EGFR-Mutant NSCLC Treated With Erlotinib: A Role for Upfront Radiation Therapy?:Metastatic Non-Small Cell Lung CancerPatel, S. / Rimner, A. / Foster, A. / Zhang, Z. / Woo, K. M. / Yu, H. A. / Riely, G. J. / Wu, A. J. et al. | 2014
- S46
-
Japanese Multi-institutional Study of Stereotactic Body Radiation Therapy for Totally 380 Patients With Lung Metastases:Metastatic Non-Small Cell Lung CancerOnishi, H. / Matsumoto, Y. / Miyakawa, A. / Yamashita, H. / Nomiya, T. / Niibe, Y. / Nakata, K. / Kuriyama, K. / Komiyama, T. / Marino, K. et al. | 2014
- S47
-
Cardiac Safety of Afatinib: Review of Clinical Trial Data:Metastatic Non-Small Cell Lung CancerEwer, M. S. / Patel, K. / O’Brien, D. / Lorence, R. M. et al. | 2014
- S49
-
Effect of Thyroid Transcription Factor-1 (TTF-1) on Outcome Following Chemotherapy for Advanced Pulmonary Adenocarcinoma:Metastatic Non-Small Cell Lung CancerDoherty, M. / O'Connor, E. / Hannon, D. / O'Reilly, A. / Grogan, L. / Hennessy, B. / Breathnach, O. / Morris, P. et al. | 2014
- S50
-
Investigating the Molecular Profile of Lung Adenocarcinoma: A Single-Institution Analysis:Metastatic Non-Small Cell Lung CancerSteuer, C. / Behera, M. / Rossi, M. / Fisher, K. / Sica, G. / Gal, A. / Pakkala, S. / Pillai, R. / Owonikoko, T. / Khuri, F. et al. | 2014
- S51
-
Does Systemic Therapy Matter After Stereotactic Radiosurgery for Brain Metastases From Lung Cancer?:Metastatic Non-Small Cell Lung CancerPatel, S. / Mourad, W. F. / Patel, L. / Young, R. / Kabarriti, R. / Bernstein, M. / Glanzman, J. / Mani, K. / Santiago, T. / Ohri, N. et al. | 2014
- S52
-
A Phase 1 Trial of X-396, a Novel ALK Inhibitor, in Patients With Advanced Solid Tumors:Novel Therapies/Experimental TherapiesHorn, L. / Blumenscheine, G. / Wakelee, H. A. / Arkenau, T. H. / Dukart, G. / Harrow, K. / Liang, C. / Gibbons, J. J. / Lovly, C. M. / Infante, J. R. et al. | 2014
- S53
-
Efficacy of MET Inhibitors in NSCLC With CBL Alterations:Novel Therapies/Experimental TherapiesTan, Y. C. / Rolle, C. / Zhu, L. / Srivastava, M. K. / Sharma, S. / Salgia, R. et al. | 2014
- S54
-
A Novel Integrated VMAT/IMRT Technique for the Treatment of Non-Small Cell Lung Cancer:Novel Therapies/Experimental TherapiesZhao, N. / Yang, R. / Wang, J. et al. | 2014
- S55
-
Population-Based Analysis of Cause-Specific Mortality in Older Esophageal Cancer Patients Treated With Conformal Radiation Therapy or Intensity Modulated Radiation Therapy:Outcomes/Health Services ResearchLin, S. H. / Zhang, N. / Godby, J. / Wang, J. / Marsh, G. D. / Liao, Z. / Komaki, R. U. / Ho, L. / Hofstetter, W. L. / Swisher, S. G. et al. | 2014
- S56
-
Effect of Prior Cancer on Outcomes in Advanced Lung Cancer: Implications for Clinical Trial Eligibility and Accrual:Outcomes/Health Services ResearchGerber, D. E. / Laccetti, A. L. / Xuan, L. / Halm, E. A. / Pruitt, S. L. et al. | 2014
- S57
-
Survival Trends in Histologic Subtypes of Metastatic Non-Small Cell Lung Cancer (mNSCLC) in the United States: 2000-2010:Outcomes/Health Services ResearchOlszewski, A. J. / Ali, S. / Witherby, S. M. et al. | 2014
- S58
-
Real-World Use of Systemic Anticancer Treatment by Histology and Line of Therapy in U.S. Medicare Patients With Advanced Non-Small Cell Lung Cancer:Outcomes/Health Services ResearchOrsini, L. S. / Korytowsky, B. / Petrilla, A. / Wisnivesky, J. P. / Craver, C. / Salvati, M. / Hines, D. / Donga, P. Z. / Blanchette, C. / Wade, R. L. et al. | 2014
- S59
-
Tobacco Cessation Perspectives and Practice Among U.S. Radiation Oncology Residents:Outcomes/Health Services ResearchBraunstein, S. E. / Singer, L. / Silveira, W. R. / Fogh, S. et al. | 2014
- S60
-
Description of ALK+ NSCLC Patient Characteristics and ALK Testing Patterns:Outcomes/Health Services ResearchWakelee, H. A. / Sasane, M. / Zhang, J. / Macalalad, A. R. / Galebach, P. / Jarvis, J. / Kageleiry, A. / Huang, Q. / Culver, K. / Wu, E. Q. et al. | 2014
- S61
-
Cost Effectiveness of Nab-Paclitaxel Plus Carboplatin (nab-PC) Relative to Bevacizumab Plus Solvent-Based Paclitaxel and Carboplatin (B+sb-PC) in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC):Outcomes/Health Services ResearchHirsh, V. / Berger, A. / Binder, G. / Langer, C. / Ong, T. J. / Renschler, M. / Bornheimer, R. / Whiting, S. / Oster, G. et al. | 2014
- S62
-
Quantification of ALK From Non-Small Cell Lung Cancer (NSCLC) FFPE Tissue by Targeted Mass Spectrometry:Outcomes/Health Services ResearchHembrough, T. / Liao, W. / Hartley, C. P. / Thyparambil, S. / An, E. / Burrows, J. / Tafe, L. J. et al. | 2014
- S64
-
Preclinical Testing Demonstrates Striking Efficacy of STA-12-8666, an Hsp90 Inhibitor–Targeted SN-38 Conjugate, in Small Cell Lung Cancer:Small Cell Lung CancerBoumber, Y. / Gaponova, A. / Nikonova, A. S. / Deneka, A. / Kudinov, A. / Chikwem, A. / Egleston, B. L. / Litwin, S. / Duncan, J. S. / Duncan, K. et al. | 2014
- S65
-
Epigenetic Analysis of Small Cell Lung Cancer Defines Distinct Disease Subsets:Small Cell Lung CancerRudin, C. M. / Connis, N. / Hann, C. L. / Poirier, J. T. et al. | 2014
- S66
-
Nadir White Blood Cell, Absolute Neutrophil, and Absolute Lymphocyte Counts During Concurrent Chemoradiation Therapy Are Associated With Worse Outcomes in Patients With Limited-Stage Small Cell Lung Cancer:Small Cell Lung CancerWei, X. / Allen, P. K. / Liao, Z. / Skinner, H. D. / Welsh, J. W. / Gomez, D. R. / Nguyen, Q. / Lin, S. H. / Heymach, J. V. / Cox, J. D. et al. | 2014
- S67
-
Early Venous Thromboembolic Events Are Associated With Worse Prognosis in Patients With Lung Cancer:Supportive Care/Palliation/NursingKourelis, T. / Wysokinska, E. M. / Wang, Y. / Yang, P. / Tafur, A. J. / Mansfield, A. S. et al. | 2014
- S68
-
A Comparison of Palliative Inpatient Management Strategies for Cancer-Related Superior Vena Cava Obstruction:Supportive Care/Palliation/NursingHall, W. A. / Steuer, C. E. / Nickleach, D. C. / Behera, M. / Owonikoko, T. K. / Higgins, K. A. / Khuri, F. R. / Curran, W. J. / Ramalingam, S. S. et al. | 2014
- S69
-
Autoantibodies Against p16 Protein-Derived Peptides Predict Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy:Translational ResearchWang, W. / Wei, J. / Zhong, W. et al. | 2014
- S71
-
Prediction of NSCLC Survival With the PAM50 Breast Cancer Signature:Translational ResearchSiegfried, J. M. / Lin, Y. / Dacic, S. / Stabile, L. P. / Diergaarde, B. / Lin, H. / Nukui, T. / Romkes, M. et al. | 2014
- S72
-
A Plasma MicroRNA Panel to Diagnose Esophageal Squamous Cell Carcinoma and Predict the Effect of Radiation Therapy:Translational ResearchYu, Q. / Li, B. / Fu, S. et al. | 2014
- S73
-
A Comprehensive Genome-Based Mutational Analysis by Next Generation Sequencing in 22 Consecutive Patients With Thoracic Malignancies:Translational ResearchAnderson, B. W. / Chang, K. / Funk, R. K. / Sio, T. T. / Molina, J. R. / Miller, R. C. et al. | 2014
- S74
-
Prognostic Roles of CTLA-4 and PDCD1 Gene Expression in Non-Small Cell Lung Cancer:Translational ResearchDeng, L. / Na, F. / He, J. / Chen, B. / Xue, J. / Zhou, L. / Lu, Y. et al. | 2014
- S75
-
Shall We Treat Small Cell Esophageal Carcinoma (SCEC) Like Small Cell Lung Cancer (SCLC)?: Comparison of the Expression Profiles of SCEC, SCLC, and Esophageal Carcinoma (EC):Translational Researchdi, l. / Yu-xin, S. / Jing, Z. / Li-yi, X. / Wei-xin, Z. / Xiao-long, F. / Guo-liang, J. / Min, F. et al. | 2014
- S76
-
Circulating Tumor Cells (CTCs) in Advanced Lung Cancer: Prognostic Impact of Quantification and Morphology by 2 Separate Techniques:Translational ResearchHashemi Sadraei, N. / Williams, A. / Du, L. / Pennell, N. / Ma, P. / Jacobs, B. / Ao, Z. / Rawal, S. / McConnell, M. / Haddad, A. et al. | 2014
- S77
-
RAD50 Expression Predicts for Locoregional Failure and Distant Metastatic Recurrence After Postoperative Radiation Therapy in Resected Non-Small Cell Lung Cancer:Translational ResearchLin, S. H. / Gudikote, J. / Giri, U. / Fujimoto, J. / Wang, J. / Wei, C. / Chen, H. / Farnia, B. / Gomez, D. R. / Story, M. D. et al. | 2014
- S78
-
Increased Rates of Pneumonitis in Patients Receiving Stereotactic Ablative Radiation Therapy for Central Versus Peripheral Lung Tumors:Treatment ToxicityChaudhuri, A. / Tang, C. / Trakul, N. / Wynne, J. / Loo, B. W. / Diehn, M. et al. | 2014
- S79
-
Radiation Does Not Add to Cardiac Specific Death in Patients With Lung Cancer:Treatment ToxicityPham, A. / Arora, S. / Wernicke, A. / Nori, D. / Chao, K. / Parashar, B. et al. | 2014
- S80
-
Decreased Risk of Radiation Pneumonitis With Coincident Concurrent Use of Angiotensin-Converting Enzyme Inhibitors in Patients Receiving Lung Stereotactic Body Radiation Therapy (SBRT):Treatment ToxicityAlite, F. / Surucu, M. / Mescioglu, I. / Harkenrider, M. et al. | 2014
-
Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) Maintenance as Monotherapy or in Combination With Bevacizumab (BEV) for Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Chemotherapy:Metastatic Non-Small Cell Lung CancerRizvi, N. A. / Antonia, S. J. / Shepherd, F. A. / Chow, L. Q. / Goldman, J. / Shen, Y. / Chen, A. C. / Gettinger, S. et al. | 2014
-
Which Lung Tumors Shrink During Fractionated Radiation and How Does This Influence Outcome?: Appropriately Selecting Tumor and Treatment Characteristics for Adaptive Radiation Therapy Protocols:Novel Therapies/Experimental TherapiesKilburn, J. M. / Lucas, J. T. / Soike, M. H. / Ayala-Peacock, D. / Kuremsy, J. G. / Blackstock, A. / Hinson, W. H. / Miller, A. A. / Petty, W. J. / Munley, M. T. et al. | 2014
-
Should All Limited-Stage Small Cell Lung Cancer Be Treated Alike?: Impact of AJCC Stage on Brain Metastasis, Survival, and Patterns of Failure:Small Cell Lung CancerWu, A. J. / Gillis, A. / Foster, A. / Woo, K. / Zhang, Z. / Gelblum, D. Y. / Downey, R. J. / Rosenzweig, K. E. / Ong, L. / Perez, C. A. et al. | 2014
-
Differences in Circulating Angiogenic Biomarkers as Prognosticator for Outcome in Bevacizumab-Treated Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Patients:Translational ResearchBatus, M. / Pithadia, R. / Kubasiak, J. / Fhied, C. / Ibrahem, Z. / Melinamani, S. / Fughhi, I. / Lie, W. / Basu, S. / Fidler, M. et al. | 2014
-
Author Index| 2014
-
Switch Maintenance With Sunitinib (S) in Advanced Non-Small Cell Lung Cancer (NSCLC): An Alliance (CALGB 30607), Randomized, Placebo-Controlled Phase 3 Trial:Metastatic Non-Small Cell Lung CancerSocinski, M. A. / Wang, X. / Baggstrom, M. / Gu, L. / Stinchcombe, T. / Edelman, M. / Baker, S. / Mannuel, H. / Crawford, J. / Vokes, E. et al. | 2014
-
Peripheral White Blood Cell Counts May Be a Significant Factor for Overall Survival in Non-Small Cell Lung Cancer Patients Treated With Radiation Therapy:Advocacy/SurvivorshipZhao, J. / Al-Basheer, A. / Dasher, B. / Frank, M. / Hao, Z. / Howington, J. / Kaminski, J. / Stewart, J. / Ye, P. et al. | 2014
-
Predictive Significance of Actinin-4 (ACTN4) Gene Expression in Early-Stage Non-Small Cell Lung Cancer (NSCLC):Early-Stage Non-Small Cell Lung CancerYamada, T. / Honda, K. et al. | 2014
-
Comparison of Overall and Cause-Specific Survivals of Stage III Non-Small Cell Lung Cancer (NSCLC) Treated With Carboplatin- or Cisplatin-Based Concurrent Chemoradiation Therapy Using SEER-Medicare Data (1992-2007):Locally Advanced Non-Small Cell Lung CancerKim, E. / Biswas, T. / Dowlati, A. / Sharma, N. / Machtay, M. et al. | 2014
-
Continuous Intravenous Pumping of Recombinant Human Endostatin Combined With Concurrent Chemoradiation Therapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer: Preliminary Data of a Prospective Multicenter Phase 1/2 Clinical Trial (NCT01733589):Locally Advanced Non-Small Cell Lung CancerHui, Z. / Ma, H. / Wu, R. / Tang, Y. / Men, Y. / Liang, J. / Chen, M. / Wang, L. et al. | 2014
-
Analysis of Outcomes in Diabetic Patients in a Phase 3 Trial of Nab-Paclitaxel (nab-P) Plus Carboplatin (C) in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC):Locally Advanced Non-Small Cell Lung CancerHirsh, V. / Owen, S. P. / Ko, A. / Renschler, M. / Socinski, M. A. et al. | 2014
-
Detection of Tumor Volume Regression and Motion Changes During Radiation Therapy for Primary Thoracic Esophageal Cancer Based on 4DCT Scans:Mesothelioma, Thymic Malignancies, and Other Thoracic MalignanciesWang, J. Z. / Li, J. / Wang, W. / Ma, Z. / Zhang, Y. et al. | 2014
-
Long-term Survival, Clinical Activity, and Safety of Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC):Metastatic Non-Small Cell Lung CancerGettinger, S. N. / Horn, L. / Gandhi, L. / Spigel, D. R. / Antonia, S. J. / Rizvi, N. A. / Powderly, J. D. / Heist, R. S. / Carvajal, R. D. / Jackman, D. M. et al. | 2014
-
Results of the Afatinib Expanded Access Program (EAP): Efficacy and Safety:Metastatic Non-Small Cell Lung CancerKim, E. S. / Halmos, B. / Kohut, I. F. / Patel, T. / Rostorfer, R. D. / Spira, A. I. / Cseh, A. / McKay, J. / Wallenstein, G. / Mileham, K. F. et al. | 2014
-
Higher Dose of Palliative Thoracic Radiation Is Associated With Improved Survival for Patients With Stage IV Non-Small Cell Lung Cancer:Metastatic Non-Small Cell Lung CancerRajpara, R. S. / Gillespie, T. W. / Nickleach, D. C. / Liu, Y. / Lipscomb, J. / Fernandez, F. G. / Mikell, J. L. / Ramalingam, S. S. / Owonikoko, T. K. / Pillai, R. N. et al. | 2014
-
Racial/Ethnic Variations in Lung Cancer Incidence and Mortality, Adjusted for Smoking Behavior: Results From the Women's Health Initiative:Outcomes/Health Services ResearchPatel, M. I. / Wang, A. / Kapphahn, K. / Kubo, J. / Desai, M. / Chlebowski, R. / Simon, M. / Bird, C. / Corbie-Smith, G. / Gomez, S. et al. | 2014
-
Ultrasensitive Detection of Circulating Tumor DNA in Non-Small Cell Lung Cancer by Deep Sequencing:Translational ResearchDiehn, M. / Bratman, S. V. / Newman, A. M. / Neal, J. W. / Wakelee, H. A. / Merritt, R. E. / Shrager, J. B. / Loo, B. W. / Alizadeh, A. et al. | 2014
-
Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer:Translational ResearchFerguson, B. D. / Kanteti, R. S. / Tan, Y. / Liu, R. / Gayed, M. J. / Vokes, E. E. / Ferguson, M. K. / Iafrate, A. J. / Gill, P. S. / Salgia, R. et al. | 2014
-
A Pilot Study on Imaging of Integrin αvβ3 With RGD PET/CT in Suspected Lung Cancer Patients:Diagnosis/StagingGao, S. / Liu, N. / Li, W. / Zhao, S. / Teng, X. / Fu, Z. / Sun, X. / Zheng, J. / Ma, L. / Lu, H. et al. | 2014
-
Prophylactic Irradiation of Surgical Tract Sites in the Era of Radical Pleurectomy for Malignant Pleural Mesothelioma:Mesothelioma, Thymic Malignancies, and Other Thoracic MalignanciesBarsky, A. R. / Buckley, J. P. / Friedberg, J. S. / Culligan, M. / Hahn, S. M. / Cengel, K. A. / Simone, C. B. et al. | 2014
-
Oligometastatic Non-Small Cell Lung Cancer Treated With Curative Intent:Metastatic Non-Small Cell Lung CancerWalker, P. / Rosenman, J. / Arastu, H. / Leinweber, C. / Aljumaily, R. / Biswas, T. / Russo, S. / Parent, T. / Eubanks, S. et al. | 2014
-
Aerosolized MANS and BIO-11006 Peptides Inhibit Lung Cancer Metastasis in SCID Mice:Metastatic Non-Small Cell Lung CancerParikh, I. / Long, W. A. / Yin, Q. / Fang, S. / Adler, K. B. et al. | 2014
-
Unique Pattern of Metastasis to the Adnexa in ALK Rearranged Non-Small Cell Lung Cancer:Metastatic Non-Small Cell Lung CancerWest, A. H. / Yamada, S. D. / MacMahon, H. / Ali, S. M. / Lukas, R. V. / Salgia, R. et al. | 2014
-
Two-Year Results of a NCCN Guideline–Based CT Lung Screening Program:Prevention/ScreeningHashim, J. A. / McKee, A. B. / French, R. / Wald, C. / Hesketh, P. J. / Lamb, C. R. / Williamson, C. / Flacke, S. / McKee, B. J. et al. | 2014
-
Table of Contents| 2014
-
Molecular Profiling in Small Cell Lung Cancer and Lung Neuroendocrine Tumors:Small Cell Lung CancerFeldman, R. / Astsaturov, I. / Millis, S. / Subramaniam, D. / Liu, S. V. et al. | 2014
-
Lung Adenocarcinoma Staging Based on 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ (AIS) and Minimally Invasive Adenocarcinoma (MIA):Diagnosis/StagingBehera, M. / Steuer, C. / Gal, A. / Owonikoko, T. / Khuri, F. / Ramalingam, S. / Sica, G. et al. | 2014
-
Elderly Patients Undergoing SBRT for Inoperable Early-Stage NSCLC Achieve Similar Outcomes to Younger Patients:Early-Stage Non-Small Cell Lung CancerMancini, B. R. / Park, H. S. / Harder, E. / Rutter, C. E. / Corso, C. D. / Decker, R. H. / Husain, Z. A. et al. | 2014
-
Predictors of 30-Day Mortality Following Resection of Early-Stage NSCLC: An Analysis of the National Cancer Data Base:Early-Stage Non-Small Cell Lung CancerHusain, Z. A. / Kim, A. W. / Yu, J. B. / Decker, R. H. / Corso, C. et al. | 2014
-
Efficacy and Biomarker Data From BEYOND: A Randomized Phase 3 Study of First-Line Chemotherapy ± Bevacizumab in Chinese Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer:Locally Advanced Non-Small Cell Lung CancerZhou, C. / Wu, Y. / Chen, G. / Liu, X. / Zhu, Y. / Lu, S. / Feng, J. / He, J. / Han, B. / Wang, J. et al. | 2014
-
Locoregional Control and Toxicity After Treatment With Intensity Modulated Radiation Therapy (IMRT) to the Thoracic Cavity in Patients With Nonmetastatic Malignant Pleural Mesothelioma (MPM): A Feasibility Study:Mesothelioma, Thymic Malignancies, and Other Thoracic MalignanciesBlake, M. / Macedo, O. / Corona, F. / Bacon-Fonseca, L. / Mendez, G. / Sanchez, R. / Arrieta, O. et al. | 2014
-
Randomized Phase 2 Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Single-Agent Chemotherapy in Previously Treated KRAS Mutant Advanced Non-Small Cell Lung Cancer (NSCLC):Metastatic Non-Small Cell Lung CancerGerber, D. E. / Socinski, M. A. / Neal, J. W. / Wakelee, H. A. / Shirai, K. / Sequist, L. V. / Rosovsky, R. / Lilenbaum, R. / Bastos, B. R. / Huang, C. et al. | 2014
-
EGFR Exon 20 Alterations in Lung Adenocarcinomas and Their Impact on Overall Survival and Response to EGFR TKI:Metastatic Non-Small Cell Lung CancerNaidoo, J. / Sima, C. S. / Rodriguez, K. / Busby, N. / Arcila, M. E. / Yu, H. A. et al. | 2014
-
Evaluation of Hospitalization Trends in Lung Cancer Patients With Hyponatremia:Outcomes/Health Services ResearchKazi, H. A. / Behera, M. / Steuer, C. / Pillai, R. N. / Owonikoko, T. K. / Khuri, F. R. / Ramalingam, S. S. et al. | 2014
-
Tumor Biomarker Evaluation of 6785 Patients for Combination Treatment Strategies in NSCLC:Translational ResearchFeldman, R. / Xiu, J. / Salgia, R. et al. | 2014
-
Genetics and Epigenetics of the INK4 Locus (9p) in Relation to Age of Onset in Non-Small Cell Lung Cancer:Translational ResearchBuckingham, L. / Nichols, T. / Barbanera, W. et al. | 2014
-
Postoperative Radiation Therapy (PORT) Is Associated With Better Survival in Non-Small Cell Lung Cancer With Involved N2 Lymph Nodes:Locally Advanced Non-Small Cell Lung CancerMikell, J. L. / Gillespie, T. W. / Hall, W. A. / Nickleach, D. C. / Liu, Y. / Lipscomb, J. / Ramalingam, S. S. / Rajpara, R. S. / Force, S. D. / Fernandez, F. G. et al. | 2014
-
High-Dose Radiation Therapy for the Treatment of Pleural Mesothelioma After Pleurectomy/Decortication or Biopsy: Long-term Follow-up, Acute and Late Toxicity:Mesothelioma, Thymic Malignancies, and Other Thoracic MalignanciesParisi, E. / Romeo, A. / Ghigi, G. / Delmonte, A. / Dipalma, B. / Micheletti, S. / Neri, E. / Sarnelli, A. / Arienti, C. / Polico, R. et al. | 2014
-
Epidermal Growth Factor Receptor (EGFR)-Mediated Adverse Events (AEs) in Patients (pts) With EGFR-Mutation Positive (EGFR M+) Non-Small Cell Lung Cancer (NSCLC) Treated With Afatinib (A):Metastatic Non-Small Cell Lung CancerWu, Y. / Geater, S. L. / Mok, T. / O'Byrne, K. J. / Schuler, M. H. / Sequist, L. V. / Yang, J. C. / Massey, D. / O’Brien, D. / Zazulina, V. et al. | 2014
-
Assessing Quality of Care (QC) Near End of Life (EOL): Use of Natural Language Processing (NLP) to Identify Brain Metastasis (BM) Cases for Evaluation of Radiation Therapy (RT) Receipt:Outcomes/Health Services ResearchRyoo, J. J. / Zheng, C. / Gould, M. K. / Kagan, A. R. / Lien, W. W. et al. | 2014
-
Clinical Pathway Adherence Improvement: A Quality Engagement Initiative for Lung Cancer:Outcomes/Health Services ResearchChiappori, A. / Antonia, S. / Peabody, J. / Kubal, T. / Letson, D. et al. | 2014
-
System Economic Impact of the miRNA Signature Classifier (MSC) Test for Management of Patients With Suspicious Lung Nodules:Prevention/ScreeningRomeo, E. / Gustavsen, G. / Buckingham, J. / Cole, D. / Narrow, D. / Sozzi, G. / Boeri, M. / Pastorino, U. / Erlander, M. G. et al. | 2014
-
The Association of Prechemotherapy Neutrophil–Lymphocyte Ratio With Survival in Non-Small Cell Lung Cancer Patients:Prevention/ScreeningMangla, A. / Thekkekara, R. / Yadav, U. / Mohajer, R. / Lad, T. et al. | 2014
-
Evaluation of Prognostic Variables in Patients With Small Cell Lung Cancer: The Role of Volumetric Response to Initial Therapy in Determining the Benefit of Prophylactic Cranial Irradiation:Small Cell Lung CancerBhatt, N. / Dutta, N. W. / Rios, J. / McCullough, K. T. / Silverman, C. L. / Woo, S. Y. / El-Ghamry, M. N. / Kloecker, G. / Dunlap, N. E. et al. | 2014
-
Next-Generation Sequencing (NGS) in Advanced Lung Cancer in the Community to Prospectively Guide Clinical Trial Selection:Translational ResearchMa, Z. / Bauer, T. M. / Chandra, P. K. / Haynes, D. J. / Prescott, J. L. / Stults, D. M. / Jones, S. F. / Hainsworth, J. D. / Infante, J. R. / Burris, H. A. et al. | 2014
-
Noninvasive Pulmonary Nodule Elastometry by CT and Deformable Image Registration:Diagnosis/StagingNegahdar, M. / Shultz, D. B. / Eyben, R. V. / Fasola, C. / Yu, A. S. / Tian, L. / Fleischmann, D. / Gable, L. / Shan, X. / Diehn, M. et al. | 2014
-
Detecting the Variations of the Spatial Position and Overlap Ratio for Primary Thoracic Esophageal Cancer Target During Radiation Therapy Based on Repeated 4-Dimensional CT Scans:Mesothelioma, Thymic Malignancies, and Other Thoracic MalignanciesWang, J. Z. / Li, J. / Wang, W. / Zhang, Y. / Ding, Y. / Liu, T. / Shang, D. et al. | 2014
-
Clinically Relevant Gene Sequencing in Lung Cancer:Metastatic Non-Small Cell Lung CancerThompson, P. / Bechara, R. / Parks, C. / Redmond, T. / Dhillon, N. et al. | 2014
-
EZH2 Protein Expression as a Prognostic Marker for Tumor Progression and Brain Metastasis in Patients With Lung Adenocarcinoma:Metastatic Non-Small Cell Lung CancerGross, J. / Raparia, K. et al. | 2014
-
Local Treatment Improves Survival in NSCLC Patients With Synchronous Brain Oligometastases:Metastatic Non-Small Cell Lung CancerGuo, G. / Lambert, P. / Ahmed, N. / Schroeder, G. / Fewer, D. / Quon, H. / Loewen, S. et al. | 2014
-
Updated Data of a Phase 1/2 Study (AF-001JP) of Alectinib, a CNS-Penetrant, Highly Selective ALK Inhibitor in ALK-rearranged Advanced NSCLC:Metastatic Non-Small Cell Lung CancerTamura, T. / Seto, T. / Nakagawa, K. / Maemondo, M. / Inoue, A. / Hida, T. / Yoshioka, H. / Harada, M. / Ohe, Y. / Nogami, N. et al. | 2014
-
Stage III Non-Small Cell Lung Cancer Treated Without Concurrent Chemotherapy: What Is the Optimal Radiation Dose?:Locally Advanced Non-Small Cell Lung CancerRimner, A. / Din, S. / Shaikh, F. / Foster, A. / Tyagi, N. / Abi Aad, S. / Paik, P. / Yorke, E. D. / Chaft, J. E. / Gelblum, D. Y. et al. | 2014
-
Evaluation of Diffusion-Weighted MRI to Differentiate Atelectasis From Lung Cancer in Radiation Therapy Planning:Locally Advanced Non-Small Cell Lung CancerSaraiya, S. / Hugo, G. / Karki, K. / Olsen, K. / Groves, R. / Ford, J. / Weiss, E. et al. | 2014
-
First-Line Monotherapy With Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Advanced Non-Small Cell Lung Cancer (NSCLC): Safety, Efficacy, and Correlation of Outcomes With PD-L1 Status:Metastatic Non-Small Cell Lung CancerRizvi, N. A. / Shepherd, F. A. / Antonia, S. J. / Brahmer, J. R. / Chow, L. Q. / Goldman, J. / Juergens, R. / Borghaei, H. / Ready, N. E. / Gerber, D. E. et al. | 2014
-
Cost Effectiveness Analysis of Stereotactic Body Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer:Outcomes/Health Services ResearchLester-Coll, N. H. / Goldberg, S. B. / Yu, J. B. / Decker, R. H. et al. | 2014
-
Genomic Characterization of Non-Small Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing:Translational ResearchAraujo, L. / Timmers, C. / Liu, T. / Yilmaz, S. / Natarajan, T. / Zhang, J. / Shilo, K. / Zhao, W. / Amann, J. / Lammers, P. et al. | 2014
-
Noninvasive, Highly Specific Detection of T790M-Mediated Acquired Resistance in EGFR Mutant NSCLC Using a Novel Droplet Digital PCR (ddPCR)–Based Cell-free Plasma DNA (cfDNA) Assay:Translational ResearchSacher, A. G. / Mach, S. / Messineo, M. / Jackman, D. M. / Jänne, P. A. / Paweletz, C. P. / Oxnard, G. R. et al. | 2014
-
Oncogenic ARAF as a New Driver in Lung Adenocarcinoma:Translational ResearchAraujo, L. / Amann, J. / Imielinski, M. / Greulich, H. / Meyerson, M. / Carbone, D. et al. | 2014
-
X-Ray Fluorescence CT as a Novel Imaging Modality for Improved Radiation Therapy Target Delineation:Translational ResearchAhmad, M. / Bazalova, M. / Xiang, L. / Xing, L. et al. | 2014
-
Fluorescence Endomicroscopy as a Tool to Assess Radiation-Induced Lung Damage, Protection, and Regeneration:Translational ResearchPerez, J. R. / Vallieres, M. / Ybarra, N. / Maria, O. / Chagnon, F. / Lesur, O. / El Naqa, I. et al. | 2014
-
Personalized Quantification of Imaging Doses to Children and Adults Scanned by Standard Thoracic Cone Beam CT in Radiation Therapy:Treatment ToxicityZhang, Y. / Wu, H. / Chen, Z. / Knisely, J. P. / Nath, R. / Yue, H. / Feng, Z. / Bao, S. / Deng, J. et al. | 2014
-
Efficacy and Safety Results From a Phase 2, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy in Advanced Squamous-Cell Non-Small Cell Lung Cancer (sq NSCLC):Metastatic Non-Small Cell Lung CancerHirsch, F. R. / Govindan, R. / Zvirbule, Z. / Braiteh, F. / Rittmeyer, A. / Belda Iniesta, C. / Isla, D. / Cosgriff, T. / Boyer, M. / Ueda, M. et al. | 2014
-
Analysis of Predictive Factors in a Phase 3 Trial of Nab-Paclitaxel (nab-P) Plus Carboplatin (C) as First-Line Therapy for Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC):Metastatic Non-Small Cell Lung CancerHirsh, V. / Page, R. D. / Ko, A. / Renshler, M. / Socinski, M. A. et al. | 2014
-
Lung Cancer Mutation Status and Targeted Therapy Predict for Outcomes in the Setting of Brain Metastasis Treated With Radiosurgery:Metastatic Non-Small Cell Lung CancerWang, T. J. / Saad, S. / Qureshi, Y. H. / Jani, A. / Sisti, M. B. / Bruce, J. N. / McKhann, G. M. / Lassman, A. B. / Cheng, S. K. / Isaacson, S. R. et al. | 2014
-
NRF2 Is a Novel Oncogene and Biomarker of Therapeutic Resistance in Non-Small Cell Lung Cancer:Novel Therapies/Experimental TherapiesAbazeed, M. / Xu, C. / Adams, D. / Tamayo, P. / Loeffler, J. / Suh, J. / Meyerson, M. / Wong, K. / Hammerman, P. et al. | 2014
-
Non-Small Cell Lung Cancer Clinicopathologic Features and Survival Outcomes in Asian/Pacific Islanders Residing in the United States: A SEER Analysis:Outcomes/Health Services ResearchHamid, M. S. / Shameem, R. / Ghafoor, K. / George, J. / Mina, B. / Sullivan, K. et al. | 2014
-
Age Disparity Between Current and Former Smokers at Time of Diagnosis of Lung Cancer:Outcomes/Health Services ResearchCampling, B. / Lai, Y. / Ye, Z. / Axelrod, R. / Bar Ad, V. / Lu, B. / Werner-Wasik, M. / Cowan, S. / Nathaniel, E. / Yang, H. et al. | 2014
-
Dosimetry and Survival From an Adaptive Radiation Therapy Clinical Trial for Limited-Stage Small Cell Lung Cancer:Small Cell Lung CancerRowe, L. / Krauze, A. / Hanson, J. / Yee, D. et al. | 2014
-
An International Multi-institutional Planning Study Evaluating Treatment Planning and Plan Acceptability Metrics for Spine Stereotactic Body Radiation Therapy (SBRT):Supportive Care/Palliation/NursingTanaka, H. / Furuya, T. / Nihei, K. / Ruschin, M. E. / Pinnaduwage, D. / Ma, L. / Sahgal, A. / Karasawa, K. et al. | 2014
-
Higher Doses to Smaller Volumes Explains Higher Proton Therapy Radiation Pneumonitis Rates Found:Treatment ToxicityPham, N. / Castillo, R. / Hobbs, B. / Guerrero, T. et al. | 2014
-
A Contralateral Esophagus Sparing Technique to Limit Severe Esophagitis Associated With Concurrent Chemoradiation Therapy in Lung Cancer Patients:Treatment ToxicityAl-Halabi, H. / Paetzold, P. / Olsen, C. / Bortfeld, T. / Willers, H. et al. | 2014
-
An Individual Patient Data Meta-Analysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non-Small Cell Lung Cancer:Metastatic Non-Small Cell Lung CancerAshworth, A. / Senan, S. / Palma, D. A. / Riquet, M. / Ahn, Y. / Ricardi, U. / Congedo, M. / Gomez, D. R. / Wright, G. / Melloni, G. et al. | 2014
-
Quantitative Measurement of BIM Protein in Lung Cancer:Diagnosis/StagingHenick, B. S. / Zarrella, E. / Altan, M. / McLaughlin, J. / Schalper, K. / Velcheti, V. / Rimm, D. L. et al. | 2014
-
Accelerated Hypofractionation Versus Stereotactic Ablative Radiation Therapy (SABR) for Early-Stage Non-Small Cell Lung Cancer: Results of a Propensity Score-Matched Analysis:Early-Stage Non-Small Cell Lung CancerChiang, A. S. / Thibault, I. / Rodrigues, G. / Palma, D. / Warner, A. / Poon, I. / Soliman, H. / Jain, S. / Cheung, P. et al. | 2014
-
Metabolic Tumor Volume on FDG-PET Predicts Clinical Outcomes Following Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of ECOG-ACRIN 6668/RTOG 0235:Locally Advanced Non-Small Cell Lung CancerOhri, N. / Duan, F. / Machtay, M. / Gorelick, J. J. / Snyder, B. S. / Alavi, A. / Siegel, B. / Johnson, D. W. / Bradley, J. D. / DeNittis, A. S. et al. | 2014
-
A Blood Biomarker Dependent Survival Model for NSCLC Patients Treated With Radiation Therapy:Locally Advanced Non-Small Cell Lung CancerJin, J. / Wang, W. / Bi, N. / Ten Haken, R. K. / Schipper, M. / Sadek, R. / Zhang, H. / Lawrence, T. / Kong, F. et al. | 2014
-
Metabolic Tumor Volume Change During Radiation Therapy and Late-Course Adaptive Radiation Therapy in Patients With Non-Small Cell Lung Cancer:Locally Advanced Non-Small Cell Lung CancerLiu, N. / Zhang, G. / Gao, S. / Fu, Z. / Hu, X. / Wang, S. / Zhao, W. / Yu, Q. / Hou, W. / Lu, H. et al. | 2014
-
Accelerated Hypofractionated Radiation Therapy Plus Chemotherapy for Inoperable Locally Advanced Lung Cancer: Final Results of Long-term Follow-up:Locally Advanced Non-Small Cell Lung CancerParisi, E. / Genestreti, G. / Romeo, A. / Romagnoli, M. / Burgio, M. / Ghigi, G. / Arpa, D. / Sarnelli, A. / Tesei, A. / Polico, R. et al. | 2014
-
Treatment and Prognosis of 73 Cases With Limited-Stage Primary Esophageal Small Cell Carcinoma:Mesothelioma, Thymic Malignancies, and Other Thoracic MalignanciesWu, J. / Wang, W. / Wang, J. et al. | 2014
-
Clinical and Pathologic Characterization of Folate Receptor Alpha, Mesothelin, and Endosialin Expression in Mesotheliomas:Mesothelioma, Thymic Malignancies, and Other Thoracic MalignanciesOwonikoko, T. K. / Busari, A. / Chen, Z. / Kim, S. / Alexis, D. / Somers, E. B. / O’Shannessy, D. J. / Ramalingam, S. / Khuri, F. / Sica, G. L. et al. | 2014
-
Survival Benefit of Asian Females in the Era of Targeted Therapy for Advanced Lung Cancer:Metastatic Non-Small Cell Lung CancerBecker, D. J. / Masri, L. / Hanna, M. S. / Grossbard, M. L. / Levy, B. P. et al. | 2014
-
NSCLC Patients With Brain Metastases Treated With Platinum-Based Doublets as First-Line Therapy: Analyses From the European FRAME Observational Study:Metastatic Non-Small Cell Lung CancerSmit, E. / Moro-Sibilot, D. / de Castro Carpeño, J. / Lesniewski-Kmak, K. / Aerts, J. / Villatoro, R. / Kraaij, K. / Nacerddine, K. / D'yachkova, Y. / Smith, K. et al. | 2014
-
Circulating Tumor Cells in Peripheral and Pulmonary Venous Blood Predict Poor Long-term Survival in Surgically Resected Non-Small Cell Lung Cancer Patients:Metastatic Non-Small Cell Lung CancerLiu, Z. / Li, Y. / Zhang, R. / Chen, Z. / Han, Y. / Su, C. et al. | 2014
-
Baseline Patient-Reported Quality of Life Is Not Related to Overall Survival in Patients Receiving Stereotactic Body Radiation Therapy for Thoracic Malignancies: A Preliminary Report:Outcomes/Health Services ResearchVu, C. C. / Sio, T. T. / Chang, K. / Miller, R. C. / Garces, Y. I. / Park, S. S. / Nelson, K. E. / Sloan, J. A. / Olivier, K. R. et al. | 2014
-
Outcomes From First 3 Years of Frameless Stereotactic Radiosurgery in Treating Brain Metastases:Supportive Care/Palliation/NursingTaggar, A. / Lau, H. / Lim, G. / Nordal, R. / Khan, R. / Breitman, K. / Hudson, A. / Spencer, D. / Voroney, J. et al. | 2014
-
Evaluation of Accuracy of 4D-CT Scan in Lung Stereotactic Body Radiation Therapy:Small Cell Lung CancerBadkul, R. K. / Pokhrel, D. / Jiang, H. / Wang, F. / Kumar, P. et al. | 2014
-
Stereotactic Body Radiation Therapy for Central Lung Tumors: Outcomes and Toxicity:Treatment ToxicityMou, B. / Merrell, K. W. / Owen, D. A. / Nelson, K. E. / Garces, Y. I. / Olivier, K. R. et al. | 2014
-
Brentuximab Vedotin in Patients With CD30+ Mesothelioma:Mesothelioma, Thymic Malignancies, and Other Thoracic MalignanciesJalal, S. I. / Einhorn, L. / Shapiro, G. I. / Hilton, J. / Wheler, J. / Dowlati, A. / Josephson, N. / Sharman, J. / Burke, J. M. et al. | 2014
-
Comparison of Long-term Survival Outcomes Between Stereotactic Body Radiation Therapy and Sublobar Resection for Stage I Non-Small Cell Lung Cancer in High-Risk Operable Patients: Propensity Score-Match Analysis:Early-Stage Non-Small Cell Lung CancerMatsuo, Y. / Chen, F. / Hamaji, M. / Kawaguchi, A. / Ueki, N. / Nagata, Y. / Sonobe, M. / Morita, S. / Date, H. / Hiraoka, M. et al. | 2014
-
Survival Benefit of Surgery Following Chemoradiation Therapy for Stage III NSCLC Is Dependent on Achieving Pathologic Nodal Clearance:Locally Advanced Non-Small Cell Lung CancerHermann, G. / Ziel, E. / Bonomi, P. / Liptay, M. / Warren, W. / Chmielewski, G. / Fidler, M. / Batus, M. / Sher, D. J. et al. | 2014
-
Radiosurgery for Lung Metastases Secondary to Renal Cell Carcinoma:Mesothelioma, Thymic Malignancies, and Other Thoracic MalignanciesLederman, A. J. / Loksen, M. / Lowinger, T. / Khaleel, A. / Izon, D. / Lederman, G. S. et al. | 2014
-
Prognostic Implications of KRAS Mutation Status and KRAS Mutation Type in Patients With Advanced NSCLC Treated With Cytotoxic Chemotherapy:Metastatic Non-Small Cell Lung CancerIams, W. T. / Hames, M. L. / Chen, H. / Aston, J. L. / Horn, L. / Lovly, C. M. et al. | 2014
-
Is Lack of Dosimetric Coverage Responsible for Post-SBRT Tumor Recurrence?:Outcomes/Health Services ResearchPodder, T. K. / Biswas, T. / Yao, M. / Lo, S. / Zhang, Y. / Ellis, R. J. / Machtay, M. et al. | 2014
-
Detection of Radiation-Induced Heart Disease by Gated Myocardial Perfusion Imaging in Patients With Esophageal Cancer During RT:Prevention/ScreeningZhang, P. / Hu, X. / Yue, J. / Yang, G. / Wang, X. / Meng, X. / Sun, X. / Yu, J. et al. | 2014
-
Nutritional Factors Predict Survival in Patients Receiving Concurrent Chemoradiation Therapy for Locally Advanced Esophagus Cancer:Supportive Care/Palliation/NursingChoflet, A. / Alcorn, S. / Hales, R. et al. | 2014
-
Genomic Mechanisms Underlying the Pathogenesis of Non-Small Cell Lung Cancer (NSCLC) in Young Patients:Translational ResearchFeng, Y. / Varadan, V. / Fink, S. / zhang, W. / Yin, L. / Liu, A. / Guda, K. / Ma, P. C. et al. | 2014
-
Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Combination With Platinum-Based Doublet Chemotherapy (PT-DC) in Advanced Non-Small Cell Lung Cancer (NSCLC):Metastatic Non-Small Cell Lung CancerAntonia, S. J. / Brahmer, J. R. / Gettinger, S. / Chow, L. Q. / Juergens, R. / Shepherd, F. A. / Laurie, S. A. / Gerber, D. E. / Goldman, J. / Shen, Y. et al. | 2014
-
ACE Inhibitors Decrease the Risk of Radiation Pneumonitis Following SBRT:Early-Stage Non-Small Cell Lung CancerHarder, E. / Park, H. S. / Mancini, B. R. / Decker, R. H. et al. | 2014
-
Comparing Patterns of Recurrence and Survival in Conventionally Fractionated Radiation With Stereotactic Body Radiation Therapy for Early-Stage NSCLC:Early-Stage Non-Small Cell Lung CancerShaikh, F. / Foster, A. / Zhang, Z. / Woo, K. / Din, S. U. / Gelblum, D. / Yorke, E. D. / Rosenzweig, K. / Wu, A. J. / Rimner, A. et al. | 2014
-
Gross Target Volume as the Predictor for the Overall Survival for Stage III Non-Small Cell Lung Cancer:Locally Advanced Non-Small Cell Lung CancerSUN, J. / Zhang, X. / Chang, J. Y. / Gomez, D. / Jiang, S. / Wang, P. / Yuan, Z. / Zhao, l. / Wang, L. / Hui, Z. et al. | 2014
-
Clinical Characteristics and Outcomes for 61 Patients With Metastatic Pulmonary Carcinoids:Mesothelioma, Thymic Malignancies, and Other Thoracic MalignanciesLitvak, A. M. / Iyriboz, T. / Zakowski, M. / Woo, K. / Krug, L. / Rudin, C. / Pietanza, C. et al. | 2014
-
Meta-Analysis Examining Impact of Age on Pemetrexed (pem) Efficacy for the Treatment of Advanced Nonsquamous (NS) Non-Small Cell Lung Cancer (NSCLC):Metastatic Non-Small Cell Lung CancerPaz-Ares, L. G. / Zimmermann, A. / Ciuleanu, T. E. / Bunn, P. A. / San Antonio, B. / Denne, J. / Iturria, N. / John, W. / Scagliotti, G. V. et al. | 2014
-
A Retrospective, Population-Based Comparison of Pemetrexed and Paclitaxel for First-Line Treatment of Stage IV Non-Small Cell Lung Cancer:Metastatic Non-Small Cell Lung CancerStrouse, C. S. / Arce-Lara, C. / Whittle, J. / Santana-Davilla, R. et al. | 2014
-
Preliminary Results of a Phase 1b Study of Bavituximab (B) Plus Carboplatin (C) and Pemetrexed (P) in Chemotherapy-Naïve Stage IIIb/IV Nonsquamous NSCLC:Novel Therapies/Experimental TherapiesGrilley-Olson, J. E. / Villaruz, L. C. / Stinchcombe, T. E. / Weiss, J. / Lee, C. / Shan, J. / Ivanova, A. / Moore, D. T. / Socinski, M. A. et al. | 2014
-
Adjuvant Chemotherapy for Elderly Patients With Stage I Non-Small Cell Lung Cancer (NSCLC) With Tumors ≥ 4 cm: A SEER-Medicare Analysis:Outcomes/Health Services ResearchMalhotra, J. / Mhango, G. / Gomez, J. E. / Smith, C. B. / Galsky, M. D. / Strauss, G. M. / Wisnivesky, J. P. et al. | 2014
-
Combining Checkpoint Blockade With Radiation Therapy Results in Tumor and Immunological Responses in an Autochthonous Mouse Model of Lung Cancer:Translational ResearchWalker, A. J. / Nirscle, C. J. / Nugent, K. / Nirschle, T. R. / Harris, T. J. / Wang, H. / Sharabi, A. B. / Velerde, E. / Malek, R. / Williams, R. et al. | 2014
-
Simple Clinical Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy in Lung Cancer: A Pooled Analysis of 70 Studies:Treatment ToxicityZhao, J. / Ling, L. / Yorke, E. D. / Milano, M. T. / Liu, W. / Kavanagh, B. / Li, A. / Andy, J. / Lawrence, M. / Miften, M. et al. | 2014
-
TIME, a Phase 2b/3 Study Evaluating TG4010 in Combination With First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Phase 2b Results:Metastatic Non-Small Cell Lung CancerQuoix, E. / Losonczy, G. / Forget, F. / Chouaid, C. / Papai, Z. / Gervais, R. / Ottensmeier, C. / Szczesna, A. / Kazarnowicz, A. / Beck, J. T. et al. | 2014
-
Baseline Urinary PGE-M Is a Prognostic and Predictive Marker for Cox-2 Inhibition in Addition to Standard Chemotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC): CALGB 30801 (Alliance):Metastatic Non-Small Cell Lung CancerEdelman, M. J. / Wang, X. / Hodgson, L. / Milne, G. L. / Cheney, R. / Baggstrom, M. / Sachdev, T. / Gajra, A. / Bertino, E. / Reckamp, K. et al. | 2014
-
Phase 2 Trial of Nab-Paclitaxel Plus Carboplatin for Advanced NSCLC in Patients at Risk of Bleeding From VEGF Directed Therapies:Metastatic Non-Small Cell Lung CancerBertino, E. M. / Williams, T. M. / Shilo, K. / Villalona-Calero, M. A. / Phillips, G. S. / Mo, X. / Otterson, G. A. et al. | 2014
-
Comparative Effectiveness of Neoadjuvant Chemoradiation Therapy Versus Chemotherapy Alone Followed by Surgery for Patients With Stage III Non-Small Cell Lung Cancer (NSCLC):Outcomes/Health Services ResearchSher, D. J. / Fidler, M. / Liptay, M. J. / Koshy, M. et al. | 2014
-
Prognostic Value of the Prediagnostic Neutrophil–Lymphocyte Ratio (NLR) for the Survival of Patients With Lung Cancer:Translational ResearchAd, V. B. / Lai, Y. / Lu, B. / Palmer, J. / Myers, R. / Ye, Z. / Wang, C. / Axelrod, R. / Campling, B. / Werner-Wasik, M. et al. | 2014
-
Anamorelin for the Treatment of Cancer Anorexia-Cachexia in Advanced NSCLC Patients: Results From ROMANA 1, a Pivotal Phase 3 Study:Supportive Care/Palliation/NursingBonomi, P. / Temel, J. / Currow, D. / Fearon, K. / Gleich, L. / Yan, Y. / Friend, J. / Abernethy, A. et al. | 2014
-
Stereotactic Body Radiation Therapy (SBRT) for Stage I Non-Small Cell Lung Cancer (NSCLC): Outcomes by Fractionation, Tumor Stage and Location, and Patient Operability:Early-Stage Non-Small Cell Lung CancerSimone, C. B. / Heskel, M. / Xanthopoulos, E. P. / Corradetti, M. N. / Singhal, S. / Friedberg, J. S. / Pechet, T. T. / Kucharczuk, J. C. / Christodouleas, J. P. / Levin, W. et al. | 2014
-
Intrafraction Cone Beam Computed Tomography Imaging Evaluation During Stereotactic Body Radiation Therapy for Lung Tumors and Metastatic Tumors to the Spine:Early-Stage Non-Small Cell Lung CancerFawaz, Z. S. / Mathieu, D. / Filion, E. / Lambert, L. / Masucci, L. et al. | 2014